@article{6ce36d3317b74110ac4a3fe2c796661e,
title = "Climate change, the environment, and rhinologic disease",
abstract = "Background: The escalating negative impact of climate change on our environment has the potential to result in significant morbidity of rhinologic diseases. Methods: Evidence based review of examples of rhinologic diseases including allergic and nonallergic rhinitis, chronic rhinosinusitis, and allergic fungal rhinosinusitis was performed. Results: The lower socioeconomic population, including historically oppressed groups, will be disproportionately affected. Conclusions: We need a systematic approach to improve healthcare database infrastructure and funding to promote diverse scientific collaboration to address these healthcare needs.",
keywords = "air pollution, allergic fungal rhinosinusitis, allergic rhinitis, chronic rhinosinusitis, climate change, health disparities, nonallergic rhinitis",
author = "Jean Kim and Waugh, {Darryn W.} and Zaitchik, {Benjamin F.} and Amber Luong and Regan Bergmark and Kent Lam and Lauren Roland and Joshua Levy and Lee, {Jivianne T.} and Cho, {Do Yeon} and Murugappan Ramanathan and Fuad Baroody and Mas Takashima and Daniel O'Brien and Lin, {Sandra Y.} and Stephanie Joe and Chaaban, {Mohamad R.} and Anna Butrymowicz and Stephanie Smith and Warren Mullings",
note = "Funding Information: Jean Kim has grant funding from Genentech and GSK and has been a consultant for GSK. Regan Bergmark has grant funding from I‐Mab Biopharma. Amber Luong is a consultant for Lyra Therapeutics, Medtronics, Sanofi, and Stryker; and has served on the advisory board for ENTvantage Cx, Soundhealth, and Maxwell Biosciences. Kent Lam is a speaker for Optinose. Lauren Roland serves on the advisory board of GSK. Joshua Levy serves on the advisory board for GSK, Regeneron, and Honeywell International. Jiviannee Lee is a consultant for Medtronic, Stryker, Aerin, and Sanofi. Mas Takashima is a consultant for Aerin, Acclarent, Medtronic, and LivaNova. Mohamad Chaaban serves on the advisory board for Optinose. All other authors declare no conflicts of interest. Publisher Copyright: {\textcopyright} 2022 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.",
year = "2022",
doi = "10.1002/alr.23128",
language = "English (US)",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
}